tiprankstipranks
Trending News
More News >
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Nuvectis Pharma (NVCT) Financial Statements

Compare
116 Followers

Nuvectis Pharma Financial Overview

Nuvectis Pharma's market cap is currently $217.21M. The company's EPS TTM is $-0.44; its P/E ratio is -6.43; Nuvectis Pharma is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -19.85M$ -22.90M$ -19.23M$ -12.89M$ -10.00K
EBITDA$ -19.00M$ -22.90M$ -19.23M$ -12.89M$ -10.00K
Net Income$ -19.00M$ -22.26M$ -19.09M$ -12.89M$ -10.00K
Balance Sheet
Cash & Short-Term Investments$ 18.53M$ 19.13M$ 19.99M$ 5.74M$ 0.00
Total Assets$ 18.61M$ 19.18M$ 20.41M$ 6.66M$ 0.00
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -18.53M$ -19.13M$ -19.99M$ -5.74M$ 0.00
Total Liabilities$ 8.89M$ 6.98M$ 6.19M$ 17.66M$ 10.00K
Stockholders' Equity$ 9.71M$ 12.20M$ 14.22M$ -11.01M$ -10.00K
Cash Flow
Free Cash Flow$ -12.25M$ -15.95M$ -13.56M$ -9.50M$ 0.00
Operating Cash Flow$ -12.25M$ -15.95M$ -13.56M$ -9.50M$ 0.00
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 11.65M$ 15.09M$ 27.81M$ 15.25M$ 0.00
Currency in USD

Nuvectis Pharma Earnings and Revenue History

Nuvectis Pharma Debt to Assets

Nuvectis Pharma Cash Flow

Nuvectis Pharma Forecast EPS vs Actual EPS